-
11.
公开(公告)号:US20230194549A1
公开(公告)日:2023-06-22
申请号:US17918184
申请日:2021-04-08
Applicant: BIOMÉRIEUX , BIOASTER , HOSPICES CIVILS DE LYON
Inventor: François MALLET , Guillaume MONNERET , Virginie MOUCADEL , Alexandre PACHOT , Estelle PERONNET , Julien TEXTORIS , Fabienne VENET , Thomas RIMMELÉ
IPC: G01N33/68 , G01N33/569
CPC classification number: G01N33/6866 , G01N33/56938 , G01N2333/31 , G01N2333/52 , G01N2800/26 , G01N2800/50
Abstract: An in vitro or ex vivo method, based on the measurement of the expression of cytokine(s), from a patient's blood sample, incubated with a stimulus, for determining the risk of occurrence of a healthcare-associated infection in the patient, within seven days following the day on which the collection of the biological sample has been performed from the patient.
-
公开(公告)号:US20200318094A1
公开(公告)日:2020-10-08
申请号:US16757968
申请日:2018-10-24
Applicant: Da Volterra , Bioaster
Inventor: Jean De Gunzburg , Jean-Denis Docquier
IPC: C12N9/86 , A61K38/50 , A61K31/407 , A61K31/496 , A61K31/546
Abstract: The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability, stability in intestinal medium, improved activity against one or more antibiotics, improved specific activity and/or improved production in a host cell.
-
公开(公告)号:US20190048331A1
公开(公告)日:2019-02-14
申请号:US16078037
申请日:2017-02-22
Applicant: DA VOLTERRA , BIOASTER
Inventor: Jean DE GUNZBURG , Jean-Denis DOCQUIER
IPC: C12N9/86 , A61K9/00 , A61K38/50 , A61K31/496 , A61K31/546 , A61K31/407
Abstract: The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability.
-
14.
公开(公告)号:US20230279492A1
公开(公告)日:2023-09-07
申请号:US18014814
申请日:2021-07-05
Applicant: BIOMÉRIEUX , BIOASTER
Inventor: Laurence VACHOT , François MALLET , Guillaume MONNERET , Virginie MOUCADEL , Alexandre PACHOT , Estelle PERONNET , Thomas RIMMELÉ , Julien TEXTORIS , Fabienne VENET
IPC: C12Q1/6883
CPC classification number: C12Q1/6883 , C12Q2600/118 , C12Q2600/158
Abstract: The invention relates to an in vitro or ex vivo method for determining the risk of incidence of a care-related infection in a patient, including a step of measuring the expression of CIITA in a biological sample from said patient.
-
公开(公告)号:US20210172948A1
公开(公告)日:2021-06-10
申请号:US17253613
申请日:2019-06-13
Applicant: MaaT PHARMA , BIOASTER
Inventor: Aurore DUQUENOY , Samuel BELLAIS , Vincent THOMAS
IPC: G01N33/569 , C12Q1/04
Abstract: The invention relates to a method for detecting the proportion of Gram-positive and Gram-negative bacteria in a complex sample. The bacteria are detected according to the Gram signal thereof. The invention enables distinction between species of Gram-positive bacteria and species of Gram-negative bacteria in a complex sample. The invention also relates to a kit for marking Gram-positive and Gram-negative bacteria, particularly for use in flow cytometry, particularly for complex samples such as human or animal microbiota samples.
-
公开(公告)号:US10988749B2
公开(公告)日:2021-04-27
申请号:US16078037
申请日:2017-02-22
Applicant: DA VOLTERRA , BIOASTER
Inventor: Jean De Gunzburg , Jean-Denis Docquier
IPC: C12N9/86 , A61K9/00 , A61K31/407 , A61K31/496 , A61K31/546 , A61K38/50
Abstract: The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability.
-
公开(公告)号:US10831156B2
公开(公告)日:2020-11-10
申请号:US16095537
申请日:2017-04-27
Applicant: BIOMERIEUX , BIOASTER
Inventor: Alice Douet , Quentin Josso
Abstract: A device for acquisition of particles present in a sample includes a spatially coherent light source, an optical system, and an image sensor placed in the focal plane of the optical system. The image sensor is configured to capture an intensity image. A computational unit of the device is configured to construct a series of electromagnetic propagation matrices obtained for a plurality of defocusing offsets relative to a plane of focus of the optics. The computational unit is also configured to determine a first average focused electromagnetic matrix for the particles from the series of electromagnetic matrices, identifying at least one of the particles in the first electromagnetic matrix and storing the coordinates of said particle, and determining a second electromagnetic matrix at a distance of focus on a particle identified from the components of the series of electromagnetic matrices having the stored coordinates.
-
公开(公告)号:US20190062719A1
公开(公告)日:2019-02-28
申请号:US16078040
申请日:2017-02-22
Applicant: DA VOLTERRA , BIOASTER
Inventor: Jean DE GUNZBURG , Jean-Denis DOCQUIER
Abstract: The present invention relates to an isolated polypeptide having beta-lactamase activity and nucleic acid sequences encoding the polypeptide. The isolated polypeptide of the invention is a VIM-2 variant with improved properties such as improved protease stability, stability in intestinal medium, improved activity against one or more antibiotics, improved specific activity and/or improved production in a host cell.
-
19.
公开(公告)号:US20240247312A1
公开(公告)日:2024-07-25
申请号:US18014801
申请日:2021-07-05
Applicant: BIOMÉRIEUX , BIOASTER
Inventor: Laurence VACHOT , François MALLET , Guillaume MONNERET , Virginie MOUCADEL , Alexandre PACHOT , Estelle PERONNET , Thomas RIMMELÉ , Julien TEXTORIS , Fabienne VENET
IPC: C12Q1/6883 , C12Q1/6851
CPC classification number: C12Q1/6883 , C12Q1/6851 , C12Q2600/118 , C12Q2600/158
Abstract: An in vitro or ex vivo method for determining the risk of incidence of a healthcare-associated infection in a patient, including a step of measuring the expression of at least one gene encoding a pro-inflammatory cytokine receptor located on chromosome 2 in the region 2q11-2q12, in a biological sample from the patient.
-
公开(公告)号:US20230408977A1
公开(公告)日:2023-12-21
申请号:US18031663
申请日:2021-10-19
Applicant: BIOMERIEUX , BIOASTER
Inventor: Zohreh SEDAGHAT , Quentin JOSSO , Fabian ROL
IPC: G03H1/00
CPC classification number: G03H1/0005 , G03H2001/0816
Abstract: A digital holographic imaging technique, includes iterative steps of: a) through back-propagation to the object coordinate of a hologram field comprising a spatial distribution of amplitude corresponding to the spatial distribution of intensity of the hologram and a spatial distribution of phase, determining an object field involving a spatial distribution of absorption and of phase shift of the imaged object, b) thresholding the values of the spatial distribution of absorption and of phase shift by decreasing the values to below a respective threshold, the thresholds decreasing in each iteration, c) through repropagation of the object field to the hologram coordinate, determining a modified hologram field comprising a modified spatial distribution of amplitude and a modified spatial distribution of phase, d) replacing the spatial distribution of phase of the hologram field with the modified spatial distribution of phase, the spatial distribution of phase shift and of absorption of the imaged object being those of the object field of the last iteration.
-
-
-
-
-
-
-
-
-